Summit Therapeutics Ownership & Insider Activity

Summit Therapeutics Inc

SMMTNASDAQ

$14.63

-0.74-4.81%

마지막 업데이트: Oct 16, 7:58 PM

$14.55

-0.82-5.33%

Summit Therapeutics (SMMT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 28.5% of shares outstanding. Institutional investors hold 6.9%.

Shares Outstanding

797.750M

Shares Float

156.463M

Insider Shares Owned

220.960M

Insider % Owned

28.5%

Institutional Shares Held

54.862M

Institutional % Held

6.9%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Jun 12, 2026	Mahkam Zanganeh	CO-CHIEF EXECUTIVE OFFICER	BUY	3.810M	$13.12	$50.0M
Jun 12, 2026	Robert W Duggan	CO-CHIEF EXECUTIVE OFFICER	BUY	3.810M	$13.12	$50.0M
Jun 4, 2026	Robert W Duggan	CO-CHIEF EXECUTIVE OFFICER	BUY	100.000K	$14.60	$1.5M
Jun 4, 2026	Mahkam Zanganeh	CO-CHIEF EXECUTIVE OFFICER	BUY	100.000K	$14.60	$1.5M
Jun 4, 2026	Manmeet Soni	COO AND CFO	BUY	50.000K	$14.45	$722K